Smart pump trial aims to tame tough diabetes cases

NCT ID NCT07509060

Ongoing Disease control Sponsor: Jerzy Hohendorff Source: ClinicalTrials.gov ↗

First seen Apr 05, 2026 · Last updated May 20, 2026 · Updated 4 times

Summary

This study tests whether a hybrid closed-loop insulin pump system (mylife CamAPS FX) can improve blood sugar control and quality of life in 30 adults with type 1 diabetes who have chronically high blood sugar (HbA1c ≥ 9%) and psychological challenges. Participants are randomly assigned to use the system for 12 months or to continue their usual care for 3 months before switching to the pump. The main goals are to see if the pump increases time in a healthy blood sugar range and lowers HbA1c after 3 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Medical University of Silesia in Katowice, Poland

Katowice, Poland
Poznan University of Medical Science, Poland

Poznan, Poland
University Hospital in Krakow

Krakow, Poland

Conditions

Explore the condition pages connected to this study.

TYPE 1 DIABETES MELLITUS